Literature DB >> 2994351

Effect of alpha- and beta-receptor active drugs on corneal thickness.

C B Nielsen, P J Nielsen.   

Abstract

Phenylephrine (10 mg/ml), phentolamine (10 mg/ml), isoprenaline (0.5 mg/ml) and timolol (5 mg/ml) were applied topically to one eye of volunteers with normal corneas, the other eye serving as a control. One drop of each drug was given twice a day for 3 or 4 days. Timolol was found to increase corneal thickness in both the medicated and the control eye. A significantly greater effect was noted on the eye receiving the drug directly. When isoprenaline was given for 3 days, a slight significant decrease in corneal thickness was found in both the medicated and the control eye, with the two eyes exhibiting a similar CCT change. The present results are suggestive of endothelial beta-receptor importance in the regulation of corneal thickness.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994351     DOI: 10.1111/j.1755-3768.1985.tb06819.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  10 in total

1.  Circadian variations in central corneal thickness and intraocular pressure in patients with glaucoma.

Authors:  P Fogagnolo; L Rossetti; F Mazzolani; N Orzalesi
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Comparison of central corneal thickness measurements obtained by community optometrists to those obtained in secondary care.

Authors:  Laura Hughes; Cheng Yi Loo; Brian Hogan; Huai Ling Tan; Ling Shan Tang; Andrew J Tatham
Journal:  Eye (Lond)       Date:  2018-07-23       Impact factor: 3.775

Review 3.  The thick and thin of the central corneal thickness in glaucoma.

Authors:  Graham W Belovay; Ivan Goldberg
Journal:  Eye (Lond)       Date:  2018-02-15       Impact factor: 3.775

4.  Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST.

Authors:  Masato Matsuura; Hiroshi Murata; Yuri Fujino; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  Transl Vis Sci Technol       Date:  2019-06-24       Impact factor: 3.283

5.  Biomechanical Glaucoma Factor and Corneal Hysteresis in Treated Primary Open-Angle Glaucoma and Their Associations With Visual Field Progression.

Authors:  Shuichiro Aoki; Atsuya Miki; Takashi Omoto; Yuri Fujino; Masato Matsuura; Hiroshi Murata; Ryo Asaoka
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-06-01       Impact factor: 4.799

6.  The Relationship between Corvis ST Tonometry Measured Corneal Parameters and Intraocular Pressure, Corneal Thickness and Corneal Curvature.

Authors:  Ryo Asaoka; Shunsuke Nakakura; Hitoshi Tabuchi; Hiroshi Murata; Yoshitaka Nakao; Noriko Ihara; Ulfah Rimayanti; Makoto Aihara; Yoshiaki Kiuchi
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

7.  The Relationship between Corvis ST Tonometry and Ocular Response Analyzer Measurements in Eyes with Glaucoma.

Authors:  Masato Matsuura; Kazunori Hirasawa; Hiroshi Murata; Mieko Yanagisawa; Yoshitaka Nakao; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  PLoS One       Date:  2016-08-31       Impact factor: 3.240

8.  The usefulness of CorvisST Tonometry and the Ocular Response Analyzer to assess the progression of glaucoma.

Authors:  Masato Matsuura; Kazunori Hirasawa; Hiroshi Murata; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  Sci Rep       Date:  2017-01-17       Impact factor: 4.379

9.  Using CorvisST tonometry to assess glaucoma progression.

Authors:  Masato Matsuura; Kazunori Hirasawa; Hiroshi Murata; Shunsuke Nakakura; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

10.  Association between Corneal Biomechanical Properties with Ocular Response Analyzer and Also CorvisST Tonometry, and Glaucomatous Visual Field Severity.

Authors:  Kazunori Hirasawa; Masato Matsuura; Hiroshi Murata; Shunsuke Nakakura; Yoshitaka Nakao; Yoshiaki Kiuchi; Ryo Asaoka
Journal:  Transl Vis Sci Technol       Date:  2017-06-14       Impact factor: 3.283

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.